vs

Side-by-side financial comparison of GCI Liberty, Inc. (GLIBA) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

GCI Liberty, Inc. is the larger business by last-quarter revenue ($257.0M vs $197.9M, roughly 1.3× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -150.6%, a 157.3% gap on every dollar of revenue. GCI Liberty, Inc. produced more free cash flow last quarter ($21.0M vs $17.6M).

GCI Communication Corp (GCI) is a telecommunications corporation operating in Alaska. Through its own facilities and agreements with other providers, GCI provides Internet access, landline, and cellular telephone service. It is a subsidiary of GCI Liberty, Inc.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

GLIBA vs RGEN — Head-to-Head

Bigger by revenue
GLIBA
GLIBA
1.3× larger
GLIBA
$257.0M
$197.9M
RGEN
Higher net margin
RGEN
RGEN
157.3% more per $
RGEN
6.7%
-150.6%
GLIBA
More free cash flow
GLIBA
GLIBA
$3.4M more FCF
GLIBA
$21.0M
$17.6M
RGEN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GLIBA
GLIBA
RGEN
RGEN
Revenue
$257.0M
$197.9M
Net Profit
$-387.0M
$13.3M
Gross Margin
52.5%
Operating Margin
-189.9%
9.0%
Net Margin
-150.6%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$-13.34
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$197.9M
Q3 25
$257.0M
$188.8M
Q2 25
$261.0M
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$-387.0M
$14.9M
Q2 25
$27.0M
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
GLIBA
GLIBA
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
GLIBA
GLIBA
RGEN
RGEN
Q4 25
9.0%
Q3 25
-189.9%
8.9%
Q2 25
19.5%
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
GLIBA
GLIBA
RGEN
RGEN
Q4 25
6.7%
Q3 25
-150.6%
7.9%
Q2 25
10.3%
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$0.24
Q3 25
$-13.34
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GLIBA
GLIBA
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$124.0M
$767.6M
Total DebtLower is stronger
$985.0M
$542.2M
Stockholders' EquityBook value
$1.4B
$2.1B
Total Assets
$3.0B
$2.9B
Debt / EquityLower = less leverage
0.72×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$124.0M
$748.7M
Q2 25
$104.0M
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$985.0M
$537.9M
Q2 25
$987.0M
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$1.4B
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$2.9B
Q3 25
$3.0B
$2.9B
Q2 25
$3.4B
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
GLIBA
GLIBA
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.72×
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GLIBA
GLIBA
RGEN
RGEN
Operating Cash FlowLast quarter
$76.0M
$25.7M
Free Cash FlowOCF − Capex
$21.0M
$17.6M
FCF MarginFCF / Revenue
8.2%
8.9%
Capex IntensityCapex / Revenue
21.4%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$76.0M
$48.1M
Q2 25
$226.0M
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
GLIBA
GLIBA
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$21.0M
$43.4M
Q2 25
$107.0M
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
GLIBA
GLIBA
RGEN
RGEN
Q4 25
8.9%
Q3 25
8.2%
23.0%
Q2 25
41.0%
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
GLIBA
GLIBA
RGEN
RGEN
Q4 25
4.1%
Q3 25
21.4%
2.5%
Q2 25
45.6%
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
GLIBA
GLIBA
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
8.37×
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons